April 24th 2025
From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Estrogen exposure may protect women against cataract
September 15th 2002Fort Lauderdale, FL-Estrogen-whether endogenous or from hormone replacement therapy (HRT)-appears to help prevent cataract formation, according to Australian researcher Christine Younan, MD, who reported her findings at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
Many still focus on controlling IOP, despite new definition
July 15th 2002New York-The official definition of glaucoma has changed over the years to downplay the role of IOP, although IOP does remain a central issue in the treatment and prevention of the condition. Such was the conclusion drawn from discussions at the Glaucoma 2002 meeting here.
Read More
NSAIDs may interfere with glaucoma medication
July 1st 2002San Antonio, TX-Before prescribing one of the newer medications for glaucoma, clinicians should ask what drugs the patient may be taking for aches and pains-especially non-steroidal anti-inflammatory agents (NSAIDs), including something as innocuous as aspirin, said William E. Sponsel, MD.
Read More
Various options available for correcting induced hyperopia
June 15th 2002Boston-The incidence of overcorrection following PRK and LASIK is fortunately very small, generally less than 5%. Unfortunately, the incidence of consecutive hyperopia after RK is significantly greater and, over time, becomes higher with a hyperopic shift, said Helen K. Wu, MD.
Read More
Molecule engineered to target neovascularization in AMD
June 1st 2002A genetically engineered molecule designed to kill cancers by destroying their rapidly growing blood vessels offers a new line of attack against age-related macular degeneration (AMD) and other retinal conditions, said Alan Garen, PhD.
Read More
Smooth, accurate LASIK ablation possible for myopia
May 15th 2002New Orleans-A system incorporating a narrow-beam excimer laser with an active tracking system to detect minuscule eye motions is effective in the LASIK correction of myopia and astigmatism, according to Marguerite B. McDonald, MD, clinical professor of ophthalmology at Tulane University School of Medicine here.
Read More
New antibiotic seen as more effective in fighting bacteria
April 1st 2002San Francisco-Levofloxacin (Quixin, Santen)-the new kid in the fluoroquinolone family-is less likely to encounter resistant strains of bacteria than the two older members of that antibiotic family, ofloxacin (Ocuflox, Allergan) and ciprofloxacin (Ciloxan, Alcon), according to David Hwang, MD.
Read More
Single-piece lens may produce less striae
February 15th 2002Philadelphia-A case-control study-in which each patient served as his or her own control-found that a single-piece lens may be less likely to cause vision-troubling capsular striae than a multipiece lens, said Richard Tipperman, MD.
Read More
Less demanding famciclovir regimen compares with acyclovir
February 15th 2002Galveston, TX-Three-times-a-day treatment with famciclovir (Famvir, Novartis) was as effective against ophthalmic herpes zoster as five-times-a-day acyclovir (Zovirax, Glaxo Wellcome) in a major international trial, said Stephen K. Tyring, MD, PhD.
Read More
Retinal Prosthesis May do Work of Photoreceptor Cells
November 15th 2001Houston-An artificial retina could be the answer for an estimated 1 million Americans with retinal blindness by conditions such as retinitis pigmentosa and age-related macular degeneration, said Alex Ignatiev, PhD, professor of physics, chemistry, and electrical and computer engineering at the University of Houston.
Read More
Radiation may have potential to treat subfoveal CNV
September 17th 1Augusta, GA-Despite negative results in an early trial, effortsare continuing to determine whether external-beam irradiation can slow visionloss caused by subfoveal choroidal neovascularization (CNV) in age-relatedmacular degeneration (AMD), said Dennis M. Marcus, MD.
Read More